Requirement for integrase during reverse transcription of human immunodeficiency virus type 1 and the effect of cysteine mutations of integrase on its interactions with reverse transcriptase.
about
Contribution of the C-terminal tri-lysine regions of human immunodeficiency virus type 1 integrase for efficient reverse transcription and viral DNA nuclear importA novel function for spumaretrovirus integrase: an early requirement for integrase-mediated cleavage of 2 LTR circles.HIV Genome-Wide Protein Associations: a Review of 30 Years of ResearchMultifunctional facets of retrovirus integraseHIV-1 capsid: the multifaceted key player in HIV-1 infectionHIV-1 protease and reverse transcriptase control the architecture of their nucleocapsid partnerStructural basis for functional tetramerization of lentiviral integraseThe engagement of activating FcgammaRs inhibits primate lentivirus replication in human macrophagesA Crystal Structure of the Catalytic Core Domain of an Avian Sarcoma and Leukemia Virus Integrase Suggests an Alternate Dimeric AssemblyRetroviral Integrase: Then and NowNon-catalytic site HIV-1 integrase inhibitors disrupt core maturation and induce a reverse transcription block in target cellsStructural dynamics of native and V260E mutant C-terminal domain of HIV-1 integrase.Biochemical and virological analysis of the 18-residue C-terminal tail of HIV-1 integrase.Augmentation of reverse transcription by integrase through an interaction with host factor, SIP1/Gemin2 Is critical for HIV-1 infection.Revealing domain structure through linker-scanning analysis of the murine leukemia virus (MuLV) RNase H and MuLV and human immunodeficiency virus type 1 integrase proteinsRecruitment of a SAP18-HDAC1 complex into HIV-1 virions and its requirement for viral replicationThe foamy virus genome remains unintegrated in the nuclei of G1/S phase-arrested cells, and integrase is critical for preintegration complex transport into the nucleus.Changes in the accessibility of the HIV-1 Integrase C-terminus in the presence of cellular proteins.Mechanisms and inhibition of HIV integrationRole of human immunodeficiency virus type 1 integrase in uncoating of the viral core.Altered viral fitness and drug susceptibility in HIV-1 carrying mutations that confer resistance to nonnucleoside reverse transcriptase and integrase strand transfer inhibitors.Non-Enzymatic Functions of Retroviral Integrase: The Next Target for Novel Anti-HIV Drug Development.Peptides that inhibit HIV-1 integrase by blocking its protein-protein interactions.Discovery of a small-molecule HIV-1 integrase inhibitor-binding siteThe self primer of the long terminal repeat retrotransposon Tf1 is not removed during reverse transcription.Impairment of human immunodeficiency virus type-1 integrase SUMOylation correlates with an early replication defect.HIV-1 replication in cell lines harboring INI1/hSNF5 mutations.Retroviral DNA Transposition: Themes and VariationsReverse Transcriptase and Cellular Factors: Regulators of HIV-1 Reverse Transcription.FRET analysis reveals distinct conformations of IN tetramers in the presence of viral DNA or LEDGF/p75.Human immunodeficiency virus type 1 employs the cellular dynein light chain 1 protein for reverse transcription through interaction with its integrase proteinRole of raltegravir in the management of HIV-1 infection.Incorporation of human immunodeficiency virus type 1 reverse transcriptase into virus-like particlesSignals in APOBEC3F N-terminal and C-terminal deaminase domains each contribute to encapsidation in HIV-1 virions and are both required for HIV-1 restriction.von Hippel Lindau binding protein 1-mediated degradation of integrase affects HIV-1 gene expression at a postintegration step.Eukaryotic elongation factor 1 complex subunits are critical HIV-1 reverse transcription cofactorsMolecular mechanisms by which human immunodeficiency virus type 1 integrase stimulates the early steps of reverse transcription.Interaction between Reverse Transcriptase and Integrase Is Required for Reverse Transcription during HIV-1 Replication.Genetic diversity and naturally polymorphisms in HIV type 1 integrase isolates from Maputo, Mozambique: implications for integrase inhibitorsMutations associated with failure of raltegravir treatment affect integrase sensitivity to the inhibitor in vitro.
P2860
Q24814060-37C4B0DB-CBA5-4CA3-A0D2-DBBDF3E2A9AFQ24815183-E98AF43E-D2E3-47B6-8465-2EF9F7B9390BQ26746070-3B3E54EE-03BF-4C52-8910-1B015B09EF7CQ26795766-35FEEEE7-2CC3-4038-8B71-FDAE1106604CQ26801145-36165FDC-03E5-4D12-8C98-66C5942EBB4BQ27302871-DF354CD9-458A-4544-868E-FADBDBC6BCDEQ27316560-3C9A2DFE-F809-4B09-B0DE-4E0241511489Q27485769-69EAD5D0-D198-492C-B542-278949193827Q27671859-48A329E4-72E4-407D-BFC7-49A8BC967FBBQ28073156-94502D19-87FC-4C66-ABDA-53F5DB130A61Q28536951-D91D45A1-1594-4DC2-9C9C-11F377F36083Q30009248-4C5409F7-6D22-4D08-BE69-6422371A3295Q30157084-4F22C7F8-F04C-4250-8494-CA9A841C7097Q30885857-B56C0D6D-6C5F-431B-8B99-A2AD32FC1CB8Q33257614-10FE1170-9CAD-4A20-B838-9571AC24F5C3Q33463283-7588D434-C9DB-4251-BB6A-8856D47DD0A8Q33676449-2099538E-8844-4954-A2BF-4922FDCAC7BBQ33810773-F0DA4A28-3144-47E2-8CEE-6D94F7097421Q33814406-7B9AA1B3-3D00-4A6A-8128-0316D355ACCCQ33826918-DBD7AE0B-ED2A-4975-A576-63E57C11112EQ34059119-A642AE57-E1BB-48C3-BA98-C35FF59B319AQ34226132-272DD513-9175-4AEF-AEA0-9E40C8931D94Q34320018-DF75277B-E4DC-4659-862D-69A2EFF5FF94Q34772524-4E8F304B-8C5E-42ED-B524-8C606F30A0B6Q35023991-8FD20054-DD2A-45B4-91A4-6459D3A3B08FQ35063298-9D4F55EA-0AE8-4C5E-A5E3-419D2D8D0693Q35069785-2804A454-2304-48D8-91C9-C2A056978845Q35249277-FB6DD31B-3BD6-487E-86E5-4D7DA4DA9DCCQ35260021-86B55FDA-7C83-4697-BEBD-40A6CD282AA6Q35468454-B4FC79BB-037B-4A4C-A95D-41E0B91D9241Q35487739-CD361196-718B-4070-A3B1-14BF7BD3D3BCQ35557318-E00E82ED-BAEE-44B0-A7D3-E59018C693F9Q35857486-A16F4BDF-8FF9-41C0-924B-EE8F23E83F1EQ35956555-56BDB33C-8476-4FEA-A4D6-CF8BB4345EF6Q35962942-D336734D-1C46-4C40-A2DB-4C6150D55CA4Q36066478-BCEE6A79-CA31-476F-B9D8-58145D7B6ACEQ36098878-7A7F4ED4-A2D2-41C3-96C0-B1C41B8C395FQ36281118-4EF58532-55DF-4CFE-82E4-233B6B386739Q36419510-35E108C8-F7D7-4C2A-9407-CD232F3110CAQ36538644-849E7FC5-5B49-453C-BB01-92867A57517A
P2860
Requirement for integrase during reverse transcription of human immunodeficiency virus type 1 and the effect of cysteine mutations of integrase on its interactions with reverse transcriptase.
description
2004 nî lūn-bûn
@nan
2004 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Requirement for integrase duri ...... ns with reverse transcriptase.
@ast
Requirement for integrase duri ...... ns with reverse transcriptase.
@en
type
label
Requirement for integrase duri ...... ns with reverse transcriptase.
@ast
Requirement for integrase duri ...... ns with reverse transcriptase.
@en
prefLabel
Requirement for integrase duri ...... ns with reverse transcriptase.
@ast
Requirement for integrase duri ...... ns with reverse transcriptase.
@en
P2093
P2860
P1433
P1476
Requirement for integrase duri ...... ns with reverse transcriptase.
@en
P2093
Charles Dobard
Samson A Chow
P2860
P304
P356
10.1128/JVI.78.10.5045-5055.2004
P577
2004-05-01T00:00:00Z